LOX inhibition disrupts a collagen-integrin-MYC axis as a translatable targeting strategy in invasive lobular carcinoma
Renée L. Flaherty, Flavia Hughes, George Sflomos, Carlos Henrique Venturi Ronchi, Harriet Kemp, Theodoros I. Roumeliotis, Anya A Nicholas, Giovanna Ambrosini, Amelie Ziehme, Sarah Becker, Yueyun Zhang, Hazel M. Quinn, Laura Battista, Harveena Padda, Solene Pezot, , Cathrin Brisken
LOX inhibition disrupts a collagen-integrin-MYC axis in ILC, halting tumor growth and metastasis with minimal toxicity, offering a new therapeutic strategy.
bioRxiv · Aug 27, 2025 · PreprintCancer Biology